Ubrelvy

Chemical Nameubrogepant
Dosage FormTablet (oral; 50 mg, 100 mg)
Drug ClassReceptor antagonists
SystemNervous
CompanyAllergan
Approval Year2019

Indication

  • Ubrelvy is indicated for the acute treatment of migraine with or without aura in adults.
Last updated on 10/20/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Ubrelvy (ubrogepant) Prescribing Information2019Allergan